Patents by Inventor Klaus Balschat
Klaus Balschat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11925742Abstract: A device includes a processor and a non-transitory memory having processor-executable instructions stored thereon. The device is usable with a blood treatment apparatus, such as a hemodialysis machine. The processor-executable instructions, when executed by the processor, facilitate: determining a time point with regard to puncturing a vessel of a patient, wherein puncturing the vessel of the patient is related to a blood treatment for the patient using a blood treatment apparatus; determining a time period based on the determined time point; and transmitting data related to the determined time point and/or data related to the determined time period to a receiving device.Type: GrantFiled: February 10, 2021Date of Patent: March 12, 2024Assignee: Fresenius Medical Care Deutschland GmbHInventors: Stefan Wegner, Reiner Spickermann, Klaus Balschat
-
Publication number: 20210316059Abstract: A device includes a processor and a non-transitory memory having processor-executable instructions stored thereon. The device is usable with a blood treatment apparatus, such as a hemodialysis machine. The processor-executable instructions, when executed by the processor, facilitate: determining a time point with regard to puncturing a vessel of a patient, wherein puncturing the vessel of the patient is related to a blood treatment for the patient using a blood treatment apparatus; determining a time period based on the determined time point; and transmitting data related to the determined time point and/or data related to the determined time period to a receiving device.Type: ApplicationFiled: February 10, 2021Publication date: October 14, 2021Inventors: Stefan Wegner, Reiner Spickermann, Klaus Balschat
-
Patent number: 10603420Abstract: A blood treatment device includes a heat exchanger having a first space and a second space, with a first fluid flowing through the first space and a second fluid flowing through the second space. The heat exchanger has a membrane which separates the first space from the second space, with the membrane forming a component of a capacitor having two capacitor plates, between which the membrane is located. A monitoring means is connected to the capacitor, and is configured to detect an electrical property of the capacitor, for the purpose of detecting a fluid leak from the first space to the second space.Type: GrantFiled: May 19, 2016Date of Patent: March 31, 2020Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Reiner Spickermann, Klaus Balschat, Tilman Staeblein, Arne Peters, Peter Kloeffel
-
Publication number: 20180207343Abstract: The present invention relates to a blood treatment device having a heat exchanger which has a first space and a second space, wherein the first space is flowed through by a first fluid and the second space is flowed through by a second fluid, and wherein the heat exchanger has a membrane which separates the first space from the second space, wherein the membrane forms a component of a capacitor which has two capacitor plates between which the membrane is located, and wherein monitoring means are provided which are connected to the capacitor and which are configured such that they detect an electrical property of the capacitor for the purpose of detecting a leak from the first space to the second space.Type: ApplicationFiled: May 19, 2016Publication date: July 26, 2018Applicant: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Reiner SPICKERMANN, Klaus BALSCHAT, Tilman STAEBLEIN, Arne PETERS, Peter KLOEFFEL
-
Patent number: 9782528Abstract: A container for dialysis concentrates, in particular acidic dry concentrates, has integral supporting elements. When these dry concentrates are dissolved directly by a dialysis machine to form liquid concentrates, the container must provide a volume of 4-12 liters. To impart the required stability to the container, the container includes the integral supporting elements, which manifest their supporting function only when the container is used on the dialysis machine.Type: GrantFiled: June 3, 2013Date of Patent: October 10, 2017Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Klaus Balschat, Alfred Gagel, Dirk Huemmer, Peter Kloeffel, Olaf Nicholas, Tilman Staeblein
-
Patent number: 9511182Abstract: The present invention relates to a medical treatment arrangement having at least three device parts, with the first device part being a device part which is not made for the treatment of a patient, with the second device part being made in conjunction with the third device part such that a treatment of a patient can be made with them, with the second device part being made movable relative to the first device part and relative to the third device part, and with provision furthermore being made that the first device part and the second device part and/or the second device part and the third device part being made such that energy and/or data can be unidirectionally or bidirectionally exchanged between them.Type: GrantFiled: May 20, 2011Date of Patent: December 6, 2016Assignee: FRESENIUS MEDICAL CARE DEUTSCHLAND GMBHInventors: Klaus Balschat, Berthold Breitkopf, Klaus Sauer, Marcus Hartmann, Dejan Nikolic, Alexander Heide
-
Patent number: 8676512Abstract: A method and device are provided for determining the transmembrane pressure during an extracorporeal blood treatment in which blood flows at a defined blood flow rate through an arterial blood conduit of an extracorporeal blood circuit into the inlet of a first chamber of a dialyzer, which is divided by a semipermeable membrane into the first chamber and a second chamber, and flows through a venous blood conduit from the outlet of the first chamber of the dialyzer, while dialysis liquid flows through a dialysis liquid supply conduit into the inlet of the second chamber of the dialyzer and flows through a dialaysis liquid discharge conduit from the outlet of the second chamber of the dialyzer.Type: GrantFiled: December 17, 2008Date of Patent: March 18, 2014Assignee: Fresenius Medical Care Deutchland GmbHInventors: Klaus Balschat, Alfred Gagel, Michael Kulz, Reiner Spickermann
-
Publication number: 20130333795Abstract: The invention relates to a container for dialysis concentrates, in particular acidic dry concentrates. When these dry concentrates are dissolved directly by the dialysis machine to form liquid concentrates, the containers must provide a volume of 4-12 liters. To impart the required stability to these containers, they have integral supporting elements, which manifest their supporting function only when the container is used on the dialysis machine.Type: ApplicationFiled: June 3, 2013Publication date: December 19, 2013Inventors: Klaus BALSCHAT, Alfred GAGEL, Dirk HUEMMER, Peter KLOEFFEL, Olaf NICHOLAS, Tilman STAEBLEIN
-
Patent number: 8518258Abstract: A hemodialysis machine or hemodiafiltration machine is provided that may be used directly for sampling for the connection to a hemodialyzer or for providing replacement fluid, as is required for regular microbiological testing. The machine does not require any additional components or any complex hygiene measures to prevent secondary contamination. By connecting an inventive sterile sampling set, samples can easily be taken. Closing elements and pumping mechanisms are controlled by a control unit as part of a sampling control program.Type: GrantFiled: October 22, 2007Date of Patent: August 27, 2013Assignee: Fresenius Medical Care Deutschland GmbHInventors: Klaus Balschat, Reiner Spickermann, Josef Winter
-
Publication number: 20130062265Abstract: The present invention relates to a medical treatment arrangement having at least three device parts, with the first device part being a device part which is not made for the treatment of a patient, with the second device part being made in conjunction with the third device part such that a treatment of a patient can be made with them, with the second device part being made movable relative to the first device part and relative to the third device part, and with provision furthermore being made that the first device part and the second device part and/or the second device part and the third device part being made such that energy and/or data can be unidirectionally or bidirectionally exchanged between them.Type: ApplicationFiled: May 20, 2011Publication date: March 14, 2013Inventors: Klaus Balschat, Berthold Breitkopf, Klaus Sauer, Marcus Hartmann, Dejan Nikolic, Alexander Heide
-
Patent number: 8315654Abstract: The present invention relates to an extracorporeal blood treatment device comprising a treatment unit and a device for controlling the treatment unit for preparing and carrying out the blood treatment. The blood treatment device also comprises an internal communication unit for communicating with an external communication unit. In order to the prepare the device blood treatment, the patient sends an initiation code by means of an external communication unit to the internal communication device. Routines required for preparing the blood treatment are then started. One main advantage is that the patient, for example during home dialysis, does not need to be present when the device is preparing for dialysis and the dialysis preparation can be started when the patient thinks of returning home in time for the beginning of the preparation phase.Type: GrantFiled: August 22, 2007Date of Patent: November 20, 2012Assignee: Fresenius Medical Care Deutschland GmbHInventors: Klaus Balschat, Pascal Kopperschmidt, Reiner Spickermann
-
Patent number: 8104348Abstract: The present invention relates to a method and a device for monitoring a flowing medium, in particular the blood flowing in an extracorporeal blood circulation, for the presence of air, in particular micro-bubbles. A sequence of signal pulses or a continuous signal is injected into the flowing medium, and the signal pulses or continuous signal leaving the flowing medium are received. To detect micro-bubbles, a signal pattern that is characteristic of the variation over time of the received signal pulses or the continuous signal in a predetermined period of time is extracted from the signal received. The characteristic signal pattern is compared with one or more characteristic reference patterns, and the presence of air bubbles is determined if the characteristic signal pattern deviates from the characteristic reference pattern by a predetermined amount. Statistical characteristic variables, in particular the variance, are preferably determined from the signal patterns and compared with one another.Type: GrantFiled: April 15, 2006Date of Patent: January 31, 2012Assignee: Fresenius Medical Care Deutschland GmbHInventors: Klaus Balschat, Tobias Fritsche, Alfred Gagel, Steffen Kirchner, Hans-Joachim Muench, Olaf Nicholas, Jochen Schneider, Reiner Spickermann, Santer Zur Host-Meyer
-
Publication number: 20100323724Abstract: The present invention relates to an extracorporeal blood treatment device comprising a treatment unit and a device for controlling the treatment unit for preparing and carrying out the blood treatment. The blood treatment device also comprises an internal communication unit for communicating with an external communication unit. In order to the prepare the device blood treatment, the patient sends an initiation code by means of an external communication unit to the internal communication device. Routines required for preparing the blood treatment are then started. One main advantage is that the patient, for example during home dialysis, does not need to be present when the device is preparing for dialysis and the dialysis preparation can be started when the patient thinks of returning home in time for the beginning of the preparation phase.Type: ApplicationFiled: August 22, 2007Publication date: December 23, 2010Inventors: Klaus Balschat, Pascal Kopperschmidt, Reiner Spickermann
-
Publication number: 20100280761Abstract: A method and device are provided for determining the transmembrane pressure during an extracorporeal blood treatment in which blood flows at a defined blood flow rate through an arterial blood conduit of an extracorporeal blood circuit into the inlet of a first chamber of a dialyzer, which is divided by a semipermeable membrane into the first chamber and a second chamber, and flows through a venous blood conduit from the outlet of the first chamber of the dialyzer, while dialysis liquid flows through a dialysis liquid supply conduit into the inlet of the second chamber of the dialyzer and flows through a dialaysis liquid discharge conduit from the outlet of the second chamber of the dialyzer.Type: ApplicationFiled: December 17, 2008Publication date: November 4, 2010Inventors: Klaus Balschat, Alfred Gagel, Michael Külz, Rainer Spickermann
-
Publication number: 20100130906Abstract: The invention relates to the field of equipment for renal replacement therapy. It is based on the observation that connections (14, 15, 101) already present in a hemodialysis machine or hemodiafiltration machine (10) may also be used directly for sampling for the connection to a hemodialyzer or for providing replacement fluid, as is required for regular microbiological testing. The invention does not require any additional components on the equipment or any complex hygiene measures to prevent secondary contamination. By connecting an inventive sterile sampling set, samples can easily be taken. On the equipment end, one need only to program the control unit (26) to implement the inventive method by means of corresponding control of the closing means (20, 21, 103) and the pumping mechanisms (17, 18) as part of a sampling control program.Type: ApplicationFiled: October 22, 2007Publication date: May 27, 2010Inventors: Klaus Balschat, Reiner Spickermann
-
Publication number: 20090205426Abstract: The present invention relates to a method and a device for monitoring a flowing medium, in particular the blood flowing in an extracorporeal blood circulation, for the presence of air, in particular micro-bubbles. A sequence of signal pulses or a continuous signal is injected into the flowing medium, and the signal pulses or continuous signal leaving the flowing medium are received. To detect micro-bubbles, a signal pattern that is characteristic of the variation over time of the received signal pulses or the continuous signal in a predetermined period of time is extracted from the signal received. The characteristic signal pattern is compared with one or more characteristic reference patterns, and the presence of air bubbles is determined if the characteristic signal pattern deviates from the characteristic reference pattern by a predetermined amount. Statistical characteristic variables, in particular the variance, are preferably determined from the signal patterns and compared with one another.Type: ApplicationFiled: April 15, 2006Publication date: August 20, 2009Inventors: Klaus Balschat, Tobias Fritsche, Alfred Gagel, Steffen Kirchner, Hans-Joachim Muench, Olaf Nicholas, Jochen Schneider, Reiner Spickermann, Santer Zur Host-Meyer
-
Patent number: 6804991Abstract: In order to detect a leakage in a fluid system of a blood treatment apparatus having an extracorporeal blood circuit, the pressure in the fluid system is measured continuously during a predetermined period of the duration of treatment, and the leak rates are calculated from the change in the pressure at predetermined time intervals of the predetermined period of the duration of treatment. The leakage volume in the predetermined period of the duration of treatment is calculated from the leak rates, and the leakage volume is compared with a predetermined limit value. If the leakage volume is greater than the limit value, this indicates a possible loss of leaktightness in the system. This can be verified with a conventional pressure-holding test. The method and device are characterized by the fact that it is not necessary in principle to interrupt the blood treatment in order to detect a loss of leaktightness.Type: GrantFiled: January 14, 2003Date of Patent: October 19, 2004Assignee: Fresenius Medical Care Deutschland GmbHInventors: Klaus Balschat, Helmuth Ender, Alfred Gagel, Reiner Spickermann
-
Publication number: 20030136181Abstract: In order to detect a leakage in a fluid system of a blood treatment apparatus having an extracorporeal blood circuit, the pressure in the fluid system is measured continuously during a predetermined period of the duration of treatment, and the leak rates are calculated from the change in the pressure at predetermined time intervals of the predetermined period of the duration of treatment. The leakage volume in the predetermined period of the duration of treatment is calculated from the leak rates, and the leakage volume is compared with a predetermined limit value. If the leakage volume is greater than the limit value, this indicates a possible loss of leaktightness in the system. This can be verified with a conventional pressure-holding test. The method and device are characterized by the fact that it is not necessary in principle to interrupt the blood treatment in order to detect a loss of leaktightness.Type: ApplicationFiled: January 14, 2003Publication date: July 24, 2003Applicant: Fresenius Medical Care Deutschland GmbH.Inventors: Klaus Balschat, Helmuth Ender, Alfred Gagel, Reiner Spickermann
-
Patent number: 6595944Abstract: A machine and method for preparing dialysis fluid for a dialysis machine. Fresh water is mixed with one or more dialysis fluid concentrates. The mixture of water and concentrates is conveyed into an equalizing chamber by a proportioning unit at a predetermined flow rate independent of the dialysate flow rate. Metered addition of the concentrates is performed volumetrically and is monitored on the basis of the conductivity of the dialysis fluid, which is measured by conductivity sensors. Because the mixture of water and concentrates is always conveyed at the same flow rate, the composition of the dialysis fluid can be determined with a high accuracy and the proportioning can be performed accurately.Type: GrantFiled: June 15, 2001Date of Patent: July 22, 2003Assignee: Fresenius Medical Care Deutschland GmbHInventors: Klaus Balschat, Michael Koch, Elmar Wolter
-
Publication number: 20020088752Abstract: A machine and method for preparing dialysis fluid for a dialysis machine. Fresh water is mixed with one or more dialysis fluid concentrates. The mixture of water and concentrates is conveyed into an equalizing chamber by a proportioning unit at a predetermined flow rate independent of the dialysate flow rate. Metered addition of the concentrates is performed volumetrically and is monitored on the basis of the conductivity of the dialysis fluid, which is measured by conductivity sensors. Because the mixture of water and concentrates is always conveyed at the same flow rate, the composition of the dialysis fluid can be determined with a high accuracy and the proportioning can be performed accurately.Type: ApplicationFiled: June 15, 2001Publication date: July 11, 2002Inventors: Klaus Balschat, Michael Koch, Elmar Wolter